These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 31929697)

  • 1. Endothelial dysfunction and inflammatory biomarkers as a response factor of concurrent coenzyme Q10 add-on metformin in patients with type 2 diabetes mellitus.
    Al-Kuraishy HM; Al-Gareeb AI; Shams HA; Al-Mamorri F
    J Lab Physicians; 2019; 11(4):317-322. PubMed ID: 31929697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of thioctic acid on glycemic indices and associated inflammatory-induced endothelial dysfunction in patients with type 2 diabetes mellitus: A case control study.
    Al-Nami MS; Al-Kuraishy HM; Al-Gareeb AI
    Int J Crit Illn Inj Sci; 2020 Sep; 10(Suppl 1):21-27. PubMed ID: 33376686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic profile and prolactin serum levels in men with type 2 diabetes mellitus: Old-new rubric.
    Al-Nami MS; Al-Kuraishy HM; Al-Gareeb AI; Al-Mamoori F
    Int J Crit Illn Inj Sci; 2019; 9(3):120-126. PubMed ID: 31620350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of coenzyme Q10 administration on glucose homeostasis parameters, lipid profiles, biomarkers of inflammation and oxidative stress in patients with metabolic syndrome.
    Raygan F; Rezavandi Z; Dadkhah Tehrani S; Farrokhian A; Asemi Z
    Eur J Nutr; 2016 Dec; 55(8):2357-2364. PubMed ID: 26385228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of addition of coenzyme Q10 to metformin on sirolimus-induced diabetes mellitus.
    Sun IO; Jin L; Jin J; Lim SW; Chung BH; Yang CW
    Korean J Intern Med; 2019 Mar; 34(2):365-374. PubMed ID: 29228766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of coenzyme Q
    Huang H; Chi H; Liao D; Zou Y
    Diabetes Metab Syndr Obes; 2018; 11():875-886. PubMed ID: 30568475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coenzyme Q10 administration has no effect on sICAM-1 and metabolic parameters of pediatrics with type 1 diabetes mellitus.
    Serag H; El Wakeel L; Adly A
    Int J Vitam Nutr Res; 2021 Jun; 91(3-4):315-324. PubMed ID: 31942840
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes.
    Kadoglou NP; Kapelouzou A; Tsanikidis H; Vitta I; Liapis CD; Sailer N
    Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):63-8. PubMed ID: 21031343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with metformin and coenzyme Q10 in murine experimental autoimmune arthritis.
    Jhun J; Lee S; Kim SY; Na HS; Kim EK; Kim JK; Jeong JH; Park SH; Cho ML
    Immunopharmacol Immunotoxicol; 2016; 38(2):103-12. PubMed ID: 26681425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of coenzyme Q
    Zarei P; Rezvanfar MR; Ansarihadipour H; Delavar M; Abdollahi M; Khosrowbeygi A
    J Res Med Sci; 2018; 23():91. PubMed ID: 30505329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin Monotherapy With and Without Lifestyle Changes Affects Anthropometric Parameters, Blood Pressure, Blood Glucose, and Lipid Profile in Indian Patients With Newly Diagnosed Type 2 Diabetes.
    Sen A; Kaur AP; Saxena I
    Cureus; 2024 Jun; 16(6):e62131. PubMed ID: 38868550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin and/or vildagliptin mitigate type II diabetes mellitus induced-oxidative stress: The intriguing effect.
    Al-Kuraishy HM; Sami OM; Hussain NR; Al-Gareeb AI
    J Adv Pharm Technol Res; 2020; 11(3):142-147. PubMed ID: 33102198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Ragonesi PD; Querci F; Franzetti IG; Gadaleta G; Ciccarelli L; Piccinni MN; D'Angelo A; Cicero AF
    Metabolism; 2010 Jun; 59(6):887-95. PubMed ID: 20015525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
    De Jager J; Kooy A; Lehert P; Bets D; Wulffelé MG; Teerlink T; Scheffer PG; Schalkwijk CG; Donker AJ; Stehouwer CD
    J Intern Med; 2005 Jan; 257(1):100-9. PubMed ID: 15606381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of bromocriptine-QR therapy on glycemic control in subjects with type 2 diabetes mellitus whose dysglycemia is inadequately controlled on insulin.
    Chamarthi B; Cincotta AH
    Postgrad Med; 2017 May; 129(4):446-455. PubMed ID: 28374645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of coenzyme Q10 supplementation on metabolic profile in diabetes: a systematic review and meta-analysis.
    Suksomboon N; Poolsup N; Juanak N
    J Clin Pharm Ther; 2015 Aug; 40(4):413-8. PubMed ID: 25913756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of lifestyle interventions with or without metformin therapy on serum levels of osteoprotegerin and receptor activator of nuclear factor kappa B ligand in patients with prediabetes.
    Arslan MS; Tutal E; Sahin M; Karakose M; Ucan B; Ozturk G; Cakal E; Biyikli Gencturk Z; Ozbek M; Delibasi T
    Endocrine; 2017 Feb; 55(2):410-415. PubMed ID: 27743302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liraglutide suppresses non-esterified free fatty acids and soluble vascular cell adhesion molecule-1 compared with metformin in patients with recent-onset type 2 diabetes.
    Chen XM; Zhang WQ; Tian Y; Wang LF; Chen CC; Qiu CM
    Cardiovasc Diabetol; 2018 Apr; 17(1):53. PubMed ID: 29636047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes.
    Lund SS; Tarnow L; Stehouwer CD; Schalkwijk CG; Teerlink T; Gram J; Winther K; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
    Eur J Endocrinol; 2008 May; 158(5):631-41. PubMed ID: 18426821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.